(6-Fluoroimidazo[1,2-a]pyridin-3-yl)methanamine
95%
- Product Code: 37095
CAS:
1020033-25-3
| Molecular Weight: | 165.1676 g./mol | Molecular Formula: | C₈H₈FN₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09994569 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure is often incorporated into the development of compounds that interact with specific receptors in the brain, such as GABA-A receptors, which are implicated in anxiety, insomnia, and seizure disorders. Additionally, it is explored for its potential in creating novel therapeutics for conditions like depression and schizophrenia due to its ability to modulate neurotransmitter activity. Researchers also investigate its use in designing drugs with improved efficacy and reduced side effects, making it a valuable scaffold in drug discovery.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿15,813.00 |
+
-
|
(6-Fluoroimidazo[1,2-a]pyridin-3-yl)methanamine
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure is often incorporated into the development of compounds that interact with specific receptors in the brain, such as GABA-A receptors, which are implicated in anxiety, insomnia, and seizure disorders. Additionally, it is explored for its potential in creating novel therapeutics for conditions like depression and schizophrenia due to its ability to modulate neurotransmitter activity. Researchers also investigate its use in designing drugs with improved efficacy and reduced side effects, making it a valuable scaffold in drug discovery.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :